These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2367188)

  • 1. [Systemic meningococcal disease in the Norwegian Army].
    Djupesland P; Bjurne G; Aanonsen NO; Borchgrevink HM; Mundal R; Høiby EA
    Nord Med; 1990; 105(6-7):179-81. PubMed ID: 2367188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Norwegian meningococcal serogroup B outer membrane vesicle vaccine protection trials: case tracing, meningococcal antigen detection and serological diagnosis.
    Høiby EA; Bjune G; Frøholm LO; Eng J; Halstensen A; Rosenqvist E; Rønnild E; Wedege E
    NIPH Ann; 1991 Dec; 14(2):107-21; discussion 121-3. PubMed ID: 1812424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results of an efficacy trial with an outer membrane vesicle vaccine against systemic serogroup B meningococcal disease in Norway.
    Bjune G; Grønnesby JK; Høiby EA; Closs O; Nøkleby H
    NIPH Ann; 1991 Dec; 14(2):125-30; discussion 130-2. PubMed ID: 1812425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meningococcal disease in the Israel Defense Force: epidemiologic trends and new challenges.
    Grotto I; Block C; Lerman Y; Wiener M; Ashkenazi S
    Isr J Med Sci; 1995 Jan; 31(1):54-8. PubMed ID: 7836050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic work with suspected cases of systemic meningococcal disease in the Norwegian serogroup B vaccine protection trials.
    Holten E; Bruun JN; Hellum KB; Maeland JA
    NIPH Ann; 1991 Dec; 14(2):103-6; discussion 121-3. PubMed ID: 1812423
    [No Abstract]   [Full Text] [Related]  

  • 6. No evidence for serosubtype-restricted protection among teenagers vaccinated with the Norwegian group B outer membrane vesicle vaccine.
    Wedege E; Nokleby H; Bjune G
    J Infect Dis; 1999 Jul; 180(1):242; author reply 242-3. PubMed ID: 10353890
    [No Abstract]   [Full Text] [Related]  

  • 7. Meningococcal disease.
    Memish ZA; Alrajhi AA
    Saudi Med J; 2002 Mar; 23(3):259-64. PubMed ID: 11938412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meningococcal disease in the Norwegian Armed Forces 1967-1979. Some epidemiological aspects.
    Berild D; Gedde-Dahl TW; Abrahamsen T
    NIPH Ann; 1980 Dec; 3(2):23-30. PubMed ID: 6784041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meningococcal B vaccine: new drug. The only vaccine against some serogroup B meningococci.
    Prescrire Int; 2008 Jun; 17(95):95-7. PubMed ID: 18623907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meningococcal disease among United States military service members in relation to routine uses of vaccines with different serogroup-specific components, 1964-1998.
    Brundage JF; Ryan MA; Feighner BH; Erdtmann FJ
    Clin Infect Dis; 2002 Dec; 35(11):1376-81. PubMed ID: 12439801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent developments in vaccines to prevent meningococcal serogroup B infections.
    Vermont CL; van den Dobbelsteen GP; de Groot R
    Curr Opin Mol Ther; 2003 Feb; 5(1):33-8. PubMed ID: 12669468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis.
    Holst J; Martin D; Arnold R; Huergo CC; Oster P; O'Hallahan J; Rosenqvist E
    Vaccine; 2009 Jun; 27 Suppl 2():B3-12. PubMed ID: 19481313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The strategy to control New Zealand's epidemic of group B meningococcal disease.
    O'Hallahan J; Lennon D; Oster P
    Pediatr Infect Dis J; 2004 Dec; 23(12 Suppl):S293-8. PubMed ID: 15597072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meningococcal disease and prevention at the Hajj.
    Borrow R
    Travel Med Infect Dis; 2009 Jul; 7(4):219-25. PubMed ID: 19717104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Passive protection in the infant rat protection assay by sera taken before and after vaccination of teenagers with serogroup B meningococcal outer membrane vesicle vaccines.
    Toropainen M; Saarinen L; Wedege E; Bolstad K; Mäkelä PH; Käyhty H
    Vaccine; 2005 Sep; 23(40):4821-33. PubMed ID: 15970361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of available outer membrane vesicle vaccines to control serogroup B meningococcal outbreaks.
    Taha MK; Zarantonelli ML; Alonso JM; Naess LM; Holst J; Feiring B; Rosenqvist E
    Vaccine; 2007 Mar; 25(14):2537-8. PubMed ID: 16460845
    [No Abstract]   [Full Text] [Related]  

  • 17. Towards a nasal vaccine against meningococcal disease, and prospects for its use as a mucosal adjuvant.
    Haneberg B; Dalseg R; Oftung F; Wedege E; Høiby EA; Haugen IL; Holst J; Andersen SR; Aase A; Meyer Naess L; Michaelsen TE; Namork E; Haaheim LR
    Dev Biol Stand; 1998; 92():127-33. PubMed ID: 9554266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of meningococcal serogroup C conjugate vaccine in Scotland.
    Mooney JD; Christie P; Robertson C; Clarke SC
    Clin Infect Dis; 2004 Aug; 39(3):349-56. PubMed ID: 15307001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New zealand epidemic strain meningococcal B outer membrane vesicle vaccine in children aged 16-24 months.
    Wong S; Lennon D; Jackson C; Stewart J; Reid S; Crengle S; Tilman S; Aaberge I; O'Hallahan J; Oster P; Mulholland K; Martin D
    Pediatr Infect Dis J; 2007 Apr; 26(4):345-50. PubMed ID: 17414400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and immunogenicity of New Zealand strain meningococcal serogroup B OMV vaccine in healthy adults: beginning of epidemic control.
    Thornton V; Lennon D; Rasanathan K; O'Hallahan J; Oster P; Stewart J; Tilman S; Aaberge I; Feiring B; Nokleby H; Rosenqvist E; White K; Reid S; Mulholland K; Wakefield MJ; Martin D
    Vaccine; 2006 Feb; 24(9):1395-400. PubMed ID: 16242221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.